mRNA |
AA-COCF3 |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.6 |
mRNA |
fluvastatin |
CTRPv2 |
pan-cancer |
AAC |
0.025 |
0.6 |
mRNA |
ISOX |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.6 |
mRNA |
Gefitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.6 |
mRNA |
lapatinib |
UHNBreast |
pan-cancer |
AAC |
-0.17 |
0.6 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.6 |
mRNA |
BRD1812 |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.6 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.6 |
mRNA |
WP1130 |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.6 |
mRNA |
NSC 74859 |
CTRPv2 |
pan-cancer |
AAC |
0.024 |
0.6 |